---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-004316"
form_type: "8-K"
ticker: "VYNE"
cik: "0001566044"
company_name: "VYNE Therapeutics Inc."
filed_at: "2023-01-17T23:59:59+00:00"
generated_at: "2026-06-20T14:42:18.899895+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# VYNE redeems all Series A Preferred Stock for $360K, eliminates series designation

## Summary
- Redeemed all outstanding Series A Convertible Preferred Stock for $360,000 (120% of stated value) on Jan 17, 2023.
- Filed Certificate of Elimination removing designation of 3,000 Series A shares with Delaware Secretary of State.
- Eliminated shares resume status as authorized but unissued and non-designated preferred stock.
- No outstanding Series A shares remain after redemption; sole holder received full payment.

## SEC filing metadata
- accession: 0001104659-23-004316
- form_type: 8-K
- ticker: VYNE
- cik: 0001566044
- company_name: VYNE Therapeutics Inc.
- filed_at: 2023-01-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1566044/000110465923004316/0001104659-23-004316-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1566044/000110465923004316/tm233612d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-004316
- JSON: https://secwatch.observer/filing/0001104659-23-004316.json
- Plain text: https://secwatch.observer/filing/0001104659-23-004316.txt

## Key facts
- Governance Changes
  VYNE Therapeutics Inc.: Filed a Certificate of Elimination to remove the designation of Series A Convertible Preferred Stock from the Amended and Restated Certificate of Incorporation, making those shares authorized but unissued preferred stock (effective 2023-01-17).
  - Change: charter amendment
  - Effective: 2023-01-17
  source text: On January 17, 2023, the Company filed a Certificate of Elimination (the “Certificate”) with the Secretary of State of the State of Delaware with respect to the Series A Preferred Stock. The Certificate (i) eliminated the previous designation of 3,000 shares of Series A Preferred Stock from the Company’s Amended and Restated Certificate of Incorporation, none of which were outstanding at the time of filing, and (ii) caused such shares of Series A Preferred Stock to resume their status as authorized but unissued and non-designated shares of preferred stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1566044/000110465923004316/0001104659-23-004316-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.